From the Department of Neurology, Mayo Clinic Florida, Jacksonville.
Circ Res. 2017 Feb 3;120(3):496-501. doi: 10.1161/CIRCRESAHA.117.310138.
Extracranial internal carotid artery atherosclerotic occlusive disease is a common ischemic stroke mechanism. Vascular risk factor control remains the cornerstone of stroke prevention in patients with both asymptomatic and symptomatic carotid occlusive diseases. Intensive medical therapy refers to the contemporary approach of antiplatelet therapy, blood pressure control, low-density lipoprotein reduction, and lifestyle modification to reduce stroke risk. Carotid revascularization with endarterectomy or angioplasty and stenting are established treatments for patients with symptomatic carotid stenosis ≥70%. Previously accepted ischemic stroke preventative strategies, such as carotid revascularization for asymptomatic carotid stenosis, require reassessment given advances in both medical therapy and surgical techniques. The purpose of this review is to describe contemporary approaches to the management of extracranial carotid atherosclerotic occlusive disease and the basis of these recommendations. Results from recently published clinical trials will be highlighted in addition to updated information from clinical trials addressing knowledge gaps in prevention of stroke caused by extracranial disease.
颅外颈内动脉粥样硬化性闭塞疾病是一种常见的缺血性脑卒中机制。血管危险因素的控制仍然是无症状和症状性颈动脉闭塞性疾病患者预防脑卒中的基石。强化医学治疗是指采用抗血小板治疗、血压控制、降低低密度脂蛋白和生活方式改变等现代方法,以降低脑卒中风险。颈动脉内膜切除术或血管成形术和支架置入术是治疗症状性颈动脉狭窄≥70%的患者的既定治疗方法。鉴于医学治疗和手术技术的进步,以前接受的预防性治疗策略,如无症状性颈动脉狭窄的颈动脉血运重建,需要重新评估。本综述的目的是描述颅外颈动脉粥样硬化性闭塞疾病管理的现代方法及其推荐依据。除了介绍针对颅外疾病引起的脑卒中预防的知识空白的临床试验的最新信息外,还将重点介绍最近发表的临床试验结果。